Dr. Leen Kawas, a trailblazer in the biotechnology industry, has made significant strides in her career, transitioning from a pharmacist to a successful entrepreneur and leader. In a recent appearance on the Recruitomics Consulting Podcast, Dr. Kawas shared valuable insights into her approach to building effective teams, the importance of diversity in clinical trials, and the need for patient involvement in drug development.
As the Managing General Partner of Propel Bio Partners, Dr. Leen Kawas is focused on recruiting the right individuals to support the company’s growth. She emphasizes the importance of a growth mindset and a “beginner’s mindset” when evaluating candidates. Dr. Kawas believes that innovative people, eager to learn, and approach problems with a fresh perspective, are invaluable assets to any team. Additionally, she recognizes the value of hiring newer professionals in the biotech industry, as they bring unique ideas and enthusiasm to the workplace. Dr. Kawas also stresses the importance of creating a work environment to foster collaboration and the complete execution of ideas.
Dr. Leen Kawas is a vocal advocate for increased diversity in the realm of clinical trials. She firmly believes that a diverse management team, particularly with more female and minority representation, is pivotal for the success of clinical trials and the recruitment of the right patient population. Dr. Kawas also underscores the need for diversity in patient selection, as it offers a more accurate representation of how a drug will impact a significant portion of society. By achieving these objectives, drug developers can not only make a significant impact on humanity but also generate substantial returns on their investments.
Dr. Leen Kawas has been a steadfast advocate for patient involvement in the drug development cycle. She firmly believes that patients should be an integral part of every phase, from drug discovery to development, rather than being involved only towards the end of the process. Dr. Kawas’ dedication to this cause began several years ago when she and her colleagues conducted patient feedback sessions to understand why certain drugs fail. By incorporating the patients’ voices in the clinical design, Dr. Kawas aims to enhance outcomes and ensure that the developed drugs meet the needs of those who will ultimately benefit from them.
Looking ahead, Dr. Leen Kawas has ambitious goals for the next decade. She aspires to invest in companies developing technologies to improve human health globally. Furthermore, Dr. Kawas is dedicated to providing internship opportunities for students and recent graduates from diverse backgrounds, recognizing the importance of fostering talent and promoting inclusivity in the biotechnology industry. Lastly, she is committed to giving back to future entrepreneurs, acknowledging the support she received throughout her career journey and its impact on her success.
Dr. Leen Kawas’ remarkable journey in the biotechnology industry inspires aspiring professionals and entrepreneurs. Her unwavering commitment to diversity, patient involvement, and talent fostering has positioned her as a visionary leader in the field. As she continues to drive Propel Bio Partners forward, Dr. Kawas’ impact on the industry and the lives of countless individuals is sure to be profound and far-reaching.
Comments are closed.